PMID: 27966990

 

    Legend: Gene, Sites

Title : Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2

Abstract :
  1. Vascular endothelial growth factor receptor-2 ( VEGFR-2 ) is an important receptor tyrosine kinase ( RTK ) that plays critical roles in both physiologic and pathologic angiogenesis
  2. The extracellular domain of VEGFR-2 is composed of seven immunoglobulin-like domains , each with multiple potential N-glycosylation sites (sequons)
  3. N-glycosylation plays a central role in RTK ligand binding, trafficking, and stability
  4. However, despite its importance, the functional role of N-glycosylation of VEGFR-2 remains poorly understood
  5. The objectives of the present study were to characterize N-glycosylation sites in VEGFR-2 via enzymatic release of the glycans and concomitant incorporation of 18O into formerly N-glycosylated sites followed by tandem mass spectrometry (MS/MS) analysis to determine N-glycosylation site occupancy and the site-specific N-glycan heterogeneity of VEGFR-2 glycopeptides
  6. The data demonstrated that all seven VEGFR-2 immunoglobulin-like domains have at least one occupied N-glycosylation site
  7. MS/MS analyses of glycopeptides and deamidated, deglycosylated ( PNGase F-treated) peptides from ectopically expressed VEGFR-2 in porcine aortic endothelial (PAE) cells identified N-glycans at the majority of the 17 potential N-glycosylation sites on VEGFR-2 in a site-specific manner
  8. The data presented here provide direct evidence for site-specific, heterogeneous N-glycosylation and N-glycosylation site occupancy on VEGFR-2
  9. The study has important implications for the therapeutic targeting of VEGFR-2 , ligand binding, trafficking, and signaling
Output (sent_index, trigger, protein, sugar, site):
  • 0. N-Glycosylation, , VEGFR-2, -, -
  • 2. N-glycosylation, , -, -, sites
  • 4. N-glycosylation, , VEGFR-2, -, -
  • 5. N-glycosylated, , -, -, sites
  • 5. N-glycosylation, , -, -, site
  • 5. N-glycosylation, , -, -, sites
  • 5. glycopeptides, , -, the site-specific N-glycan heterogeneity, glycopeptides
  • 5. heterogeneity, , -, -, glycopeptides
  • 5. occupancy, , -, -, glycopeptides
  • 5. occupancy, , -, -, site
  • 6. N-glycosylation, , -, -, site
  • 7. N-glycosylation, , -, -, sites
  • 7. VEGFR-2, , -, deamidated, deglycosylated (PNGase F-treated) peptides, peptides
  • 7. VEGFR-2, , PNGase, VEGFR-2, -
  • 7. deglycosylated, , PNGase, -, peptides
  • 7. glycopeptides, , -, -, glycopeptides
  • 8. N-glycosylation, , -, -, site
Output(Part-Of) (sent_index, protein, site):
  • 2. VEGFR-2, domain
  • 5. VEGFR-2, glycopeptides
  • 5. VEGFR-2, sites
  • 6. -, site
  • 7. VEGFR-2, sites
*Output_Site_Fusion* (sent_index, protein, sugar, site):

 

 

Protein NCBI ID SENTENCE INDEX
PNGase 59007 7
Vascular endothelial growth factor receptor-2 16542 1
VEGFR-2 16542 1,2,4,5,7,8,9
RTK 22174 1,3